Walgreens Boots Alliance and Theranos have tentatively reached accord on a $30 million agreement, according to a story published Wednesday in The Wall Street Journal. Walgreens had been seeking $140 million as part of a breach of contract suit in an attempt to recover the cost of its investment. According to reports, Theranos recently told investors it had about $54 million in cash left to settle suits, down from $187 million in January. (The Wall Street Journal)